Anti-MSLN chimeric antigen receptor-like NK cell therapy with tumor-penetrating capacity (uCAR-like NK) for solid tumors
Anti-mesothelin uCAR-like #NaturalKiller cells integrating #tumor-penetrating #peptides show enhanced targeting, infiltration, & superior #antitumor efficacy, establishing a modular nongenetic NK platform for MSLN-positive #SolidTumorTherapy.
#OpenAccess #STTT: doi.org/10.1038/s413...
1
0
0
0
